Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide PRF in Acromegaly
NCT02396953Phase 2Completed
- Sponsor
- Ipsen
- Start
- Mar 2015
- Primary completion
- Nov 2017
- Modality
- Peptides
- Countries
- 12
01
Overview
A Phase 2 trial of lanreotide in acromegaly, sponsored by Ipsen. Started Mar 2015; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02396953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396953.